SOLV
SOLV
NYSE · Health Care

Solventum Corp

$64.03
-1.66 (-2.53%)
As of Mar 24, 9:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
8.41B
Net Income
1.57B
Gross Margin
53.6%
Profit Margin
18.7%
Rev Growth
+0.8%
D/E Ratio
1.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.6% 53.6% 36.1% 36.1%
Operating Margin 25.2% 22.7% 7.9% 8.8%
Profit Margin 18.7% 17.8% 6.0% 7.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 8.41B 8.34B 2.00B 2.07B
Gross Profit 4.50B 4.47B 720.95M 746.93M
Operating Income 2.12B 1.89B 158.39M 181.53M
Net Income 1.57B 1.40B 120.01M 158.92M
Gross Margin 53.6% 53.6% 36.1% 36.1%
Operating Margin 25.2% 22.7% 7.9% 8.8%
Profit Margin 18.7% 17.8% 6.0% 7.7%
Rev Growth +0.8% +0.8% +13.3% +17.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.91B 2.91B 2.07B 2.00B
Total Equity 2.92B 2.92B 9.62B 9.86B
D/E Ratio 1.00 1.00 0.21 0.20
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 2.57B 2.43B 215.86M 222.16M
Free Cash Flow 146.72M 199.01M